AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Resmed DRC

31.980

+0.3000.95%

Volume:606.53K

Turnover:19.39M

Market Cap:46.61B

PE:2.13

High:32.100

Open:31.740

Low:31.740

Close:31.680

52wk High:42.833

52wk Low:25.425

Shares:1.46B

Float Shares:145.49M

Volume Ratio:0.88

T/O Rate:0.42%

Dividend:0.35

Dividend Rate:1.09%

EPS(TTM):15.016

EPS(LYR):15.016

ROE:24.27%

ROA:14.00%

PB:4.92

PE(LYR):2.13

Loading ...

Overview Company News Filings

Concept

Novel Coronavirus Treatment+1.12%

Capital Flow

Inflow:

Outflow:

News

Resmed Inc Stock (RMD) Moved Down by 3.15% on Sep 8: What Investors Need To Know

Is ResMed (RMD) Below Fair Value On The MatrixCare Sale?

Simply Wall St.

ResMed Launches $450 Million Accelerated Share Buyback With Citibank

MT Newswires Live

ResMed to Buy Back $450M in Stock Under Accelerated Share Repurchase Agreement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/RMD.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RMD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RMD.AU\",,,,,undefined,":{"symbol":"RMD.AU","market":"AU","secType":"STK","nameCN":"Resmed DRC","latestPrice":31.98,"timestamp":1790748720000,"preClose":31.68,"halted":0,"volume":606528,"delay":0,"changeRate":0.009469696969696993,"nameEN":"Resmed DRC","floatShares":145494856,"shares":1457529700,"eps":15.016074253983291,"marketStatus":"Not Yet Opened","change":0.3,"latestTime":"09-30 16:12:00 AEST","open":31.74,"high":32.1,"low":31.74,"amount":19390295,"amplitude":0.011364,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":15.016074253983291,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1790812800000},"marketStatusCode":0,"adr":0,"adrRate":1,"exchange":"ASX","adjPreClose":31.68,"dividendRate":0.010897,"openAndCloseTimeList":[[1790726400000,1790748000000]],"volumeRatio":0.8785063674786003,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"RMD.AU","preClose":31.98,"auctionPrice":31.95,"auctionVolume":1502,"auctionTime":1790808337558,"referenceTime":1790764203089,"auction":1,"marketStatus":"盘前竞价","timestamp":1790808337558}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RMD.AU\",,,,,undefined,":{"symbol":"RMD.AU","floatShares":145494856,"roa":"14.00%","roe":"24.27%","lyrEps":15.016074,"volumeRatio":0.8785063674786003,"shares":1457529700,"dividePrice":0.3485,"high":32.1,"amplitude":0.011364,"preClose":31.68,"low":31.74,"week52Low":25.425,"pbRate":"4.92","psRate":"5.73","week52High":42.833,"institutionHeld":0,"latestPrice":31.98,"eps":15.016074253983291,"divideRate":0.010897,"volume":606528,"delay":0,"ttmEps":15.016074253983291,"open":31.74,"prevYearClose":35.646,"prevWeekClose":31.58,"prevMonthClose":31.98,"prevQuarterClose":31.98,"fiveDayClose":31.61,"twentyDayClose":32.28,"sixtyDayClose":31.098,"dividendPayoutRate":0.02326337710008864,"dividendGrowthYears":2,"dividendGrowthRate":0.076841184280566,"fiveYearAvgDividendRate":0.01298073865708731},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RMD.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"RMD.AU","amount":0.066,"announcedDate":"2026-08-07","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-08-20","defaultRemindTime":1787097600000,"name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-24","payableDate":"2026-08-20","currency":"USD","dateTimestamp":1787061600000,"payDate":"2026-09-24"},{"market":"AU","date":"2026-08-07","symbol":"RMD.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1786024800000,"reportTimeType":"","actualEps":null},{"date":"2026-05-13","symbol":"RMD.AU","amount":0.06,"announcedDate":"2026-05-01","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-05-14","defaultRemindTime":1778630400000,"name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-05-14","currency":"USD","dateTimestamp":1778594400000,"payDate":"2026-06-18"},{"market":"AU","date":"2026-05-01","symbol":"RMD.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777557600000,"reportTimeType":"pre","actualEps":null},{"date":"2026-02-11","symbol":"RMD.AU","amount":0.06,"announcedDate":"2026-01-30","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-02-12","name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-19","payableDate":"2026-02-12","currency":"USD","dateTimestamp":1770728400000,"payDate":"2026-03-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RMD.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-08-19","recordDate":"2020-08-20","paymentDate":"2020-09-24","value":0.039,"currency":"USD"},{"executeDate":"2020-11-11","recordDate":"2020-11-12","paymentDate":"2020-12-17","value":0.039,"currency":"USD"},{"executeDate":"2021-02-10","recordDate":"2021-02-11","paymentDate":"2021-03-18","value":0.039,"currency":"USD"},{"executeDate":"2021-05-12","recordDate":"2021-05-13","paymentDate":"2021-06-17","value":0.039,"currency":"USD"},{"executeDate":"2021-08-18","recordDate":"2021-08-19","paymentDate":"2021-09-23","value":0.042,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RMD.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666712993","title":"Resmed Inc Stock (RMD) Moved Down by 3.15% on Sep 8: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2666712993","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666712993?lang=en_us&edition=fundamental","pubTime":"2026-09-09 00:15","pubTimestamp":1788884129,"startTime":"0","endTime":"0","summary":"• ResMed faced selling pressure due to Astral ventilator suspension expenses and margin pressures.\n• Sector sentiment remains constrained by GLP-1 concerns and potential Philips market re-entry.\n• ResMed completed the MatrixCare divestiture, funding accelerated share repurchases and increased dividends.","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262156444-market-movers-rmd-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMO","LU0096362180.USD","BK4581","HRTS","LU1291159041.SGD","GNMX","LU2265009873.SGD","LGHT","LU2041044095.USD","BK7007","FMED","BK4533","LU0170899867.USD","LU0289739699.SGD","RMD.AU","IE0002141913.USD","LU1061106388.HKD","LU2357305700.SGD","LU2720916845.USD","LU1720051108.HKD","BK4585","LU2506951875.HKD","IHI","LU0353189763.USD","BSX","ISBC","SYK","LU0251131958.USD","LU1720051017.SGD","LU0823416689.USD","BSX.AU","LU1923621640.USD","TMED","BK4211","BK4082","LU0128525929.USD","LU2112291526.USD","LU0345769128.USD","IE00BQXX3F31.USD","LU1989764748.USD","LU0048573561.USD","LU0187121727.USD","IE0009355771.USD","LU2506952170.USD","LU2362540622.SGD","RMD","LU2125910336.SGD","LU2125910179.SGD","LU1983299246.USD","LU1791710400.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664975258","title":"Is ResMed (RMD) Below Fair Value On The MatrixCare Sale?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664975258","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664975258?lang=en_us&edition=fundamental","pubTime":"2026-09-02 15:26","pubTimestamp":1788333970,"startTime":"0","endTime":"0","summary":"ResMed (RMD) is back in focus after Frazier Healthcare Partners completed its acquisition of MatrixCare, the company’s residential care software subsidiary, with Jonathan Lujan appointed as MatrixCare’s new chief executive officer.\nResMed’s latest move comes after a mixed year for investors, with the share price down 5.49% year to date but showing a 24.08% 90 day share price return and a 54.84% total shareholder return over three years. However, the one year total shareholder return declined...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-rmd/resmed/news/is-resmed-rmd-below-fair-value-on-the-matrixcare-sale","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-rmd/resmed/news/is-resmed-rmd-below-fair-value-on-the-matrixcare-sale","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4548","LU2177674079.SGD","BK7501","LGHT","BK4585","RMD.AU","BK4588","BK7007","LU0170899867.USD","IE00B5TLWC47.USD","BK4082","RMD","LU2008162690.USD","BK4567","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664861221","title":"ResMed Launches $450 Million Accelerated Share Buyback With Citibank","url":"https://stock-news.laohu8.com/highlight/detail?id=2664861221","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664861221?lang=en_us&edition=fundamental","pubTime":"2026-09-02 05:54","pubTimestamp":1788299644,"startTime":"0","endTime":"0","summary":"ResMed  said Tuesday it entered into a $450 million accelerated share repurchase agreement with Citigroup's  Citibank, funded with proceeds from the sale of its MatrixCare business and cash on hand.ResMed will pay Citibank $450 million on Thursday and expects an initial share delivery that day equal to 80% of that amount based on the Wednesday closing price. Final settlement is scheduled for December, according to a regulatory filing.The buyback is being conducted under a repurchase authorization for 20 million shares approved by the board in February 2014.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TFNS","LU1244550577.SGD","LU0130102774.USD","BK4082","LU0310800965.SGD","LU2125154935.USD","LU0052756011.USD","IE00B5TLWC47.USD","BK4504","LU2236285917.USD","BK4585","BK4559","LU1201861249.SGD","LU0128525689.USD","LU1668664300.SGD","BK4548","LU0130517989.USD","BK4588","LU0203345920.USD","BK4567","LGHT","LU2008162690.USD","LU0980610538.SGD","LU1791807156.HKD","LU2456880835.USD","RMD","LU0320765646.SGD","LU1074936037.SGD","LU1144417596.USD","LU0162691827.USD","IYF","LU2417539215.USD","CUL3","FTXO","LU0106831901.USD","LU1244550494.USD","LU0170899867.USD","BK7501","LU1244550221.USD","BK4566","LU1162221912.USD","LU2177674079.SGD","BK7007","LU0203347892.USD","LU0098860793.USD","LU0477156953.USD","IE00BSNM7G36.USD","RMD.AU","LU1506573853.SGD","LU0314106906.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664861984","title":"ResMed to Buy Back $450M in Stock Under Accelerated Share Repurchase Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664861984","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664861984?lang=en_us&edition=fundamental","pubTime":"2026-09-02 05:16","pubTimestamp":1788297360,"startTime":"0","endTime":"0","summary":"ResMed will buy back $450 million of its stock under an accelerated share repurchase agreement with Citibank.The buybacks are being made under a 20 million-share repurchase authorization from 2014, the medical equipment company said in a Tuesday regulatory filing. The purchase will be funded with cash on hand and proceeds from the company's sale of its MatrixCare business.The company said it will make the $450 million payment to Citibank on Thursday, and will receive 80% of that total in stock the same day. The final number of shares will be based on the stock's volume-weighted daily average price during the term of the agreement, which is set to be settled by December.ResMed said it had contemplated the transaction in its full-year guidance issued early last month.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ResMed to Buy Back $450M in Stock Under Accelerated Share Repurchase Agreement","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD","LU0170899867.USD","BK7501","LGHT","LU2008162690.USD","BK7007","BK4585","BK4504","RMD.AU","LU2177674079.SGD","BK4548","BK4588","IE00B5TLWC47.USD","BK4567","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":11,"pageCount":1,"totalSize":44,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RMD.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Novel Coronavirus Treatment","id":"package_au_concept_xgzlg","bkCode":"BK7501","changeRate":0.011197}]}}